Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hypertension × sacubitril and valsartan sodium hydrate drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Hypertension 1

Interventions

relacorilant 2 sacubitril and valsartan sodium hydrate drug combination 1 aliskiren 1 Enalapril 1 Amlodipine, Valsartan Drug Combination 1 Amlodipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06236061 2026-01-13

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Novartis

Phase 3 Completed

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡